Celada A, Aguado T, Lambert P, CRUCHAUD A
Clin Exp Immunol. 1980; 41(2):326-35.
PMID: 7438558
PMC: 1536998.
Rhodes J, Oliver S
Immunology. 1980; 40(3):467-72.
PMID: 7429540
PMC: 1458043.
Dent R, Cole P
Br J Cancer. 1981; 43(4):486-95.
PMID: 7236490
PMC: 2010636.
DOI: 10.1038/bjc.1981.71.
Uracz W, Pituch-Noworolska A, Zembala M, Popiela T, Czupryna A
J Cancer Res Clin Oncol. 1982; 104(1-2):181-90.
PMID: 7130244
DOI: 10.1007/BF00402066.
Bray J, McPherson T
Clin Exp Immunol. 1981; 44(3):629-37.
PMID: 7035033
PMC: 1537304.
Inhibition of human monocyte Fc receptor and HLA-DR antigen expression by pregnancy alpha-2 glycoprotein.
Persellin R, Rhodes J
Clin Exp Immunol. 1981; 46(2):350-4.
PMID: 6950820
PMC: 1536386.
Receptor associated defects of cultured monocytes in bronchial carcinoma.
Lukacs K, Carroll M, Hodson M, Kay A
Clin Exp Immunol. 1984; 56(2):321-9.
PMID: 6733974
PMC: 1536218.
Monocyte antibody-dependent cellular cytotoxicity in cancer patients.
De Young N, Gill P
Cancer Immunol Immunother. 1984; 18(1):54-8.
PMID: 6567479
PMC: 11039158.
DOI: 10.1007/BF00205400.
Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).
Rhodes J, Stokes P, Abrams P
Cancer Immunol Immunother. 1984; 16(3):189-92.
PMID: 6561070
PMC: 11039071.
DOI: 10.1007/BF00205428.
Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria.
Ward K, Warrell M, Rhodes J, Looareesuwan S, White N
Infect Immun. 1984; 44(3):623-6.
PMID: 6373611
PMC: 263647.
DOI: 10.1128/iai.44.3.623-626.1984.
Disordered function of mononuclear phagocytes in malignant disease.
Sokol R, Hudson G
J Clin Pathol. 1983; 36(3):316-23.
PMID: 6338057
PMC: 498204.
DOI: 10.1136/jcp.36.3.316.
Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.
Rhodes J, Jones D, Bleehen N
Clin Exp Immunol. 1983; 53(3):739-43.
PMID: 6311468
PMC: 1535636.
A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.
Nielsen H, Bennedsen J, Larsen S, Dombernowsky P, Viskum K
Cancer Immunol Immunother. 1982; 13(2):93-7.
PMID: 6297713
PMC: 11039074.
DOI: 10.1007/BF00205307.
Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid.
Rhodes J, Stokes P
Immunology. 1982; 45(3):531-6.
PMID: 6174424
PMC: 1555242.
Correlation of Fc gamma receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer.
Ilfeld D, Barzilay J, Dux Z, Ran M
Breast Cancer Res Treat. 1986; 7(3):181-6.
PMID: 3779115
DOI: 10.1007/BF01806248.
Antibody-dependent cell-mediated cytotoxicity using a murine monoclonal antibody against human colorectal cancer in cancer patients.
Takamuku K, Akiyoshi T, Tsuji H
Cancer Immunol Immunother. 1987; 25(2):137-40.
PMID: 3664531
PMC: 11038845.
DOI: 10.1007/BF00199954.
Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.
Kimura S, Sone S, Takahashi K, Uyama T, Ogura T, Monden Y
Br J Cancer. 1989; 59(4):535-9.
PMID: 2785397
PMC: 2247139.
DOI: 10.1038/bjc.1989.109.
Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.
Sone S, Utsugi T, Tandon P, Yanagawa H, Okubo A, Ogura T
Cancer Immunol Immunother. 1990; 30(6):357-62.
PMID: 2302725
PMC: 11038695.
DOI: 10.1007/BF01786885.
Phagocytic function and antibody-dependent cellular cytotoxicity of human neutrophils in the presence of N-formimidoyl thienamycin.
Rodriguez A, Barriga C, de la Fuente M
Agents Actions. 1990; 31(1-2):86-95.
PMID: 2285026
DOI: 10.1007/BF02003226.
Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.
CURRIE G, Hedley D
Br J Cancer. 1977; 36(1):1-6.
PMID: 889676
PMC: 2025452.
DOI: 10.1038/bjc.1977.147.
